13/11/24 Seminario del Prof. Trevor Hansel
Parma, 13 novembre 2024 – Seminario del Prof. Trevor Hansel dell’Imperial College, London, UK.
|
Università degli Studi di Parma
|
Società di Medicina e Scienze naturali di Parma
|
Università degli Studi di Parma – Dipartimento di Medicina e Chirurgia
Clinica Pneumologica
Scuola di Specializazione in Malattie Apparato Respiratorio
Il prof. Gaetano Caramori
Vi invita al Seminario
15.30–16,30: “New techniques to sample the lower airways
to enable precision medicine for respiratory diseases”
Professor Trevor Hansel
Airway Disease Section, National Heart &
Lung Institute, Imperial College London, UK
Parma, Mercoledì 13 Novembre 2024 ore 15,30-16,30
Aula Didattica Clinica Pneumologica, 2° piano, Padiglione 25 (Rasori),
Azienda Ospedaliero-Universitaria Ospedale Maggiore di Parma
Clicca qui per scaricare l’invito
Professor TREVOR HANSEL
In 2009 Trevor Hansel became Medical Director of the Imperial Clinical Respiratory Research Unit (ICRRU) at St Mary’s Hospital, having been Medical Director of the NHLI Clinical Studies Unit at the Royal Brompton Hospital from 1997-2009. He is also an Honorary Consultant Immunologist at St. Mary’s Hospital in London.
He obtained his medical degree in 1982 at the Welsh National School of Medicine, Cardiff and then completed higher specialist medical training in clinical immunology in Birmingham. From 1990-1993 Trevor performed clinical asthma research in Davos, Switzerland; developing methods for blood eosinophil isolation and sputum eosinophil surface marker assessment. Following this, he worked in respiratory drug development with Sandoz and Roche in Basel; working in project management and clinical development. In addition, he has regulatory experience from the Biotechnology Unit of the Medicines Control Agency (MCA) in London.
Trevor has a specialist interest in phase II clinical testing of new anti-inflammatory therapies for asthma and COPD, and has worked on a variety of challenge models in patients. In particular he is working on novel non-invasive methods to sample the airways: using synthetic absorptive matrices to measure cytokines and chemokines in nasal and bronchial mucosal lining fluid. These sampling methods have been developed on nasal allergen challenge, and he is also working on challenges with viruses, cigarette smoke, and agonists for innate immunity (LPS and poly-IC).
